Literature DB >> 10221999

Group-specific assays that distinguish between the four major types of mammalian phospholipase A2.

H C Yang1, M Mosior, C A Johnson, Y Chen, E A Dennis.   

Abstract

Phospholipase A2 (PLA2) constitutes a diverse superfamily of enzymes which catalyze the deacylation of phospholipids. At least four types of PLA2 are potentially involved in arachidonic acid release in cells and tissues. Since all of them catalyze the same enzymatic reaction, it is difficult to distinguish between them in mixtures of enzymes normally present in biological samples. Utilizing specific properties of each PLA2, we have designed distinct assay procedures which selectively and sensitively detect each type: Group VI Ca2+-independent PLA2, Group IV cytosolic Ca2+-dependent PLA2, Groups V and IIA secreted PLA2s. Each specific assay procedure is selective for a particular PLA2 type by at least fourfold and as high as four orders of magnitude relative to the other three enzymes. All assays can detect PLA2 activity with as low as subnanogram quantities of enzyme. Importantly, these assays are able to differentiate and quantitate the biochemically and structurally related enzymes, Group IIA and V sPLA2s in crude biological samples. Employing this system, we have found that iPLA2 is the dominant PLA2 in rat brain, and cPLA2 is the most abundant PLA2 in P388D1 macrophages and human amnionic WISH cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221999     DOI: 10.1006/abio.1999.4053

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  46 in total

1.  Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.

Authors:  Epolia Ramadan; Lisa Chang; Mei Chen; Kaizong Ma; F Scott Hall; George R Uhl; Stanley I Rapoport; Mireille Basselin
Journal:  Int J Neurosci       Date:  2012-03-26       Impact factor: 2.292

2.  Determination of phospholipase activity of PAF acetylhydrolase.

Authors:  Diana M Stafforini; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2012-05-29       Impact factor: 7.376

3.  Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain.

Authors:  Hyung-Wook Kim; Jagadeesh S Rao; Stanley I Rapoport; Miki Igarashi
Journal:  Biochim Biophys Acta       Date:  2010-11-09

Review 4.  Neuroinflammation and synaptic loss.

Authors:  Jagadeesh S Rao; Matthew Kellom; Hyung-Wook Kim; Stanley I Rapoport; Edmund A Reese
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

5.  Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.

Authors:  Yewon Cheon; Jee-Young Park; Hiren R Modi; Hyung-Wook Kim; Ho-Joo Lee; Lisa Chang; Jagadeesh S Rao; Stanley I Rapoport
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

6.  Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.

Authors:  Epolia Ramadan; Mireille Basselin; Jagadeesh S Rao; Lisa Chang; Mei Chen; Kaizong Ma; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-28       Impact factor: 5.176

7.  Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult mice.

Authors:  Epolia Ramadan; Helene Blanchard; Yewon Cheon; Meredith A Fox; Lisa Chang; Mei Chen; Kaizong Ma; Stanley I Rapoport; Mireille Basselin
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-01-30       Impact factor: 4.006

8.  Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.

Authors:  Ava L Taylor; Joseph V Bonventre; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

9.  Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.

Authors:  Edmund A Reese; Yewon Cheon; Epolia Ramadan; Hyung-Wook Kim; Lisa Chang; Jagadeesh S Rao; Stanley I Rapoport; Ameer Y Taha
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-07-27       Impact factor: 4.006

10.  Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice.

Authors:  Koji Kishimoto; Rung-Chi Li; Jian Zhang; Judith A Klaus; Kathleen K Kibler; Sylvain Doré; Raymond C Koehler; Adam Sapirstein
Journal:  J Neuroinflammation       Date:  2010-07-30       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.